ETE Metrics

NYS Progress to End the AIDS Epidemic by the End of 2020

NEW HIV INFECTIONS (INCIDENCE)
Reduce the number of estimated new HIV infections to
HIV STATUS AWARE
Increase the percentage of people living with HIV who know their serostatus to at least
NEW HIV DIAGNOSES
Reduce the number of new HIV diagnoses by 55% to

2020 Target 825** iUntil 2017, the method used to estimate HIV incidence used a Serologic Testing Algorithm for Recent HIV Seroconversion (STARHS) method to estimate incidence. Starting with 2017 estimates, the CDC released a new incidence estimate method based on a CD4 depletion model (CD4 methodology). The 2017 change and the 2019 updates result in estimates that are on average 32% and 10% higher respectively, than the STARHS method used at the time ETE was planned. The original goal of 750 equates to approximately 1,000 under the 2017 method and 825 under the 2019 version.

2019 Actual 1,700

2020 Target 98%

2019 Actual 91%

2020 Target 1,515

2019 Actual 2,377

(estimated)
Incidence estimates are calculated using a CDC method, which was revised in 2017 and updated again in 2019. Source: Song R, et al., 2017.
Data for this metric are produced using a CDC method and associated program that were introduced in 2017. Source: Song R, et al., 2017.
Number of newly diagnosed HIV cases reported. (NHAS 2020 Goal: 25%)
NYS HIV Surveillance System

NEWLY DIAGNOSED HIV - PERSONS WHO INJECT DRUGS
Reduce the percentage of persons newly diagnosed with HIV who indicate a history of injection drug use to
CONCURRENT AIDS DIAGNOSIS
Reduce the proportion of persons with a diagnosis of AIDS within 30 days of HIV diagnosis to
LINKAGE TO CARE
Increase the percentage of newly diagnosed persons linked to HIV medical care within 30 days of diagnosis to at least

2020 Target 2.8%

2019 Actual 4.5%

2020 Target 15.0%

2019 Actual 19.6%

2020 Target 90%

2019 Actual 83%

Includes persons who indicate IDU and MSM/IDU history. NYS HIV Surveillance System

HIV infection with simultaneous AIDS diagnosis, or AIDS diagnosis (stage 3 HIV) within 30 days.
NYS HIV Surveillance System

Newly diagnosed with any VL, CD4 or genotype within 30 days of diagnosis by diagnosis year.NHAS 2020 Goal: 85%
NYS HIV Surveillance System

RECEIVING HIV MEDICAL CARE
Increase the percentage of persons living with diagnosed HIV (PLWDH) who receive HIV medical care to
VIRAL SUPPRESSION - NEWLY DIAGNOSED HIV
Increase the percentage of persons newly diagnosed with HIV who reach viral load suppression within 3 months of diagnosis to
VIRAL SUPPRESSION - PLWDH
Increase the percentage of persons living with diagnosed HIV with suppressed viral load to

2020 Target 90%

2019 Actual 86%

2020 Target 75%

2019 Actual 59%

2020 Target 85%

2019 Actual 77%

Any VL, CD4 or genotype test in a calendar year
NYS HIV Surveillance System

VL test suppressed (<200 copies/mL) within 91 days from the date of HIV diagnosis.
NYS HIV Surveillance System

Last VL test in calendar year is non-detectable or <200 copies/ml. (NHAS 2020 Goal = 80%).
NYS HIV Surveillance System.

VIRAL SUPPRESSION - RECEIVING HIV MEDICAL CARE
Increase the percentage of PLWDH who receive care with suppressed viral load to
SUSTAINED VIRAL LOAD SUPPRESSION
Increase the percentage of PLWDH with sustained viral suppression to
TIME TO AIDS DIAGNOSIS
Reduce the percentage of persons newly diagnosed with HIV who progress to AIDS in 2 years by 50% to

2020 Target 95%

2019 Actual 89%

2020 Target 75%

2019 Actual 69%

2020 Target 5.1%

2017 Actual 5%

Last VL test in calendar year is non detectable or <200 copies/ml
NYS HIV Surveillance System

Result of <200 copies/mL on all viral load tests in the previous 2 years, among those with at least 2 viral load tests in the previous 2 years. NYS HIV Surveillance System.

AIDS diagnosis within 2 years of HIV diagnosis
NYS HIV Surveillance System

HIV RELATED DEATHS
Reduce the percentage of deaths among PLWDH directly related to HIV to 20%
STIGMA
Decrease stigma experienced among PLWDH with diagnosed HIV by at least
PrEP UTILIZATION
Increase the number of individuals filling prescriptions for PrEP to

2020 Target 20%

2018 Actual 26%

2020 Target 25%

2018 Actual 30%

2020 Target 65,000

2019 Actual 39,921

Deaths among people with diagnosed HIV are considered to be “HIV-related” if the underlying cause of death was HIV. NYS HIV Surveillance System.

Based on results of a 10 question scale looking at 4 dimensions of stigma (personalized stigma, disclosure concerns, negative self-image, and perceived public attitudes about people with HIV). NYS Medical Monitoring Project
Number of individuals filling at least one prescription for Truvada within the calendar year. Source: IDV (Integrated Dataverse) from Symphony Health and the NYS Medicaid Data Warehouse.

PrEP UTILIZATION - MEDICAID
Increase the number of Medicaid recipients filling prescriptions for PrEP to

2020 Target 30,000

2019 Actual 9,447

Number of Medicaid recipients filling at least one prescription for Truvada within the calendar year. Source: NYS Medicaid Data Warehouse

  • NYS DOH AIDS Institute, Division of HIV/STD Epidemiology, Evaluation & Partner Services. Data as of June 2020.
    • Proportions for some ETE metrics filtered by race/ethnicity group (e.g. Native American) are unstable due to low numbers and should be interpreted with caution.

    *Data displayed for New York City comes from the NYC DOHMH HIV Surveillance System, unless otherwise noted, reported as of March 31, 2020. 2020 NYS statewide goals are displayed in all instances except for the NYC-specific ETE 2020 goals for new HIV infections (660) and new HIV diagnoses (1,350).

    **Until 2017, the method used to estimate HIV incidence used a Serologic Testing Algorithm for Recent HIV Seroconversion (STARHS) method to estimate incidence. Starting with 2017 estimates, the CDC released a new incidence estimate method based on a CD4 depletion model (CD4 methodology). The 2017 change and the 2019 updates result in estimates that are on average 32% and 10% higher respectively, than the STARHS method used at the time ETE was planned. The original goal of 750 equates to approximately 1000 under the 2017 method and 825 under the 2019 version.

    ETE Metrics

    NYC Progress to End the AIDS Epidemic by the End of 2020

    NEW HIV INFECTIONS (INCIDENCE)
    Reduce the number of estimated new HIV infections to
    HIV STATUS AWARE
    Increase the percentage of people living with HIV who know their serostatus to at least
    NEW HIV DIAGNOSES
    Reduce the number of new HIV diagnoses to

    2020 Target 660 (NYC)

    2019 Actual 1,200 (NYC)

    2020 Target 98%

    2019 Actual 93% (NYC)

    2020 Target 1,350 (NYC)

    2019 Actual 1,772 (NYC)

    (estimated)
    Data for this metric are produced using a CDC method and associated program that were introduced in 2017. Source: Song R, et al., 2017.

    Data for this metric are produced using a CDC method and associated program that were introduced in 2017. Source: Song R, et al., 2017.

    Number of newly diagnosed HIV cases reported.
    NYC DOHMH HIV Surveillance System

    NEWLY DIAGNOSED HIV - PERSONS WHO INJECT DRUGS
    Reduce the percentage of persons newly diagnosed with HIV who indicate a history of injection drug use to
    CONCURRENT AIDS DIAGNOSIS
    Reduce the proportion of persons with a diagnosis of AIDS within 31 days of HIV diagnosis to
    LINKAGE TO CARE
    Increase the percentage of newly diagnosed persons linked to HIV medical care within 30 days of diagnosis to at least

    2020 Target 2.8%

    2019 Actual 3.4% (NYC)

    2020 Target 15.0%

    2019 Actual 16.6% (NYC)

    2020 Target 90%

    2019 Actual 82% (NYC)

    Includes persons who indicate IDU and MSM/IDU history. NYC DOHMH HIV Surveillance System

    HIV infection with simultaneous AIDS diagnosis, or AIDS diagnosis (stage 3 HIV) within 31 days.
    NYC DOHMH HIV Surveillance System

    Newly diagnosed with any VL, CD4 or genotype within 30 days of diagnosis by diagnosis year.NHAS 2020 Goal: 85%
    NYC DOHMH HIV Surveillance System

    RECEIVING HIV MEDICAL CARE
    Increase the percentage of persons living with diagnosed HIV (PLWDH) who receive HIV medical care to
    VIRAL SUPPRESSION - NEWLY DIAGNOSED HIV
    Increase the percentage of persons newly diagnosed with HIV who reach viral load suppression within 3 months of diagnosis to
    VIRAL SUPPRESSION - PLWDH
    Increase the percentage of persons living with diagnosed HIV with suppressed viral load to

    2020 Target 90%

    2019 Actual 93% (NYC)

    2020 Target 75%

    2019 Actual 54% (NYC)

    2020 Target 85%

    2019 Actual 83% (NYC)

    Any VL, CD4 or genotype test in NYC DOHMH HIV Surveillance System in a calendar year

    VL test suppressed (<200 copies/mL) within 91 days from the date of HIV diagnosis.
    NYC DOHMH HIV Surveillance System

    Last VL in calendar year is undetectable or <200 copies/mL. NYC DOHMH HIV Surveillance System.

    VIRAL SUPPRESSION - RECEIVING HIV MEDICAL CARE
    Increase the percentage of PLWDH who receive care with suppressed viral load to
    SUSTAINED VIRAL LOAD SUPPRESSION
    Increase the percentage of PLWDH with sustained viral suppression to
    TIME TO AIDS DIAGNOSIS
    Reduce the percentage of persons newly diagnosed with HIV who progress to AIDS in 2 years by 50% to

    2020 Target 95%

    2019 Actual 87% (NYC)

    2020 Target 75%

    2019 Actual 69% (NYC)

    2020 Target 5.1%

    2017 Actual 5.9% (NYC)

    Last VL in calendar year is undetectable or <200 copies/mL. NYC DOHMH HIV Surveillance System.

    Result of <200 copies/mL on all viral load tests in the previous 2 years, among those with at least 2 viral load tests in the previous 2 years. NYC DOHMH HIV Surveillance System.

    AIDS diagnosis within 2 years of HIV diagnosis
    NYC DOHMH HIV Surveillance System

    HIV RELATED DEATHS
    Reduce the percentage of deaths directly related to HIV to 20%
    STIGMA
    Decrease stigma experienced among PLWDH with diagnosed HIV by at least
    PrEP UTILIZATION
    Increase the number of individuals filling prescriptions for PrEP to

    2020 Target 20%

    2018 Actual 26% (NYC)

    2020 Target 25%

    2018 Actual 35% (NYC)

    2020 Target Not AvailableiCurrently there are no NYC-specific ETE 2020 targets for PrEP utilization based on the Symphony Health or Medicaid data sources.

    2019 Actual 28,259 (NYC)

    Deaths among people with HIV are considered to be “HIV-related” if the underlying cause of death was HIV. NYC DOHMH HIV Surveillance System.

    Race/ethnicity data unavailable
    Based on results of a 10 question scale looking at 4 dimensions of stigma (personalized stigma, disclosure concerns, negative self-image, and perceived public attitudes about people with HIV). NYC Medical Monitoring Project
    Number of individuals filling at least one prescription for Truvada within the calendar year. Source: IDV (Integrated Dataverse) from Symphony Health and the NYS Medicaid Data Warehouse.

    PrEP UTILIZATION - MEDICAID
    Increase the number of Medicaid recipients filling prescriptions for PrEP to

    2020 Target Not AvailableiCurrently there are no NYC-specific ETE 2020 targets for PrEP utilization based on the Symphony Health or Medicaid data sources.

    2019 Actual 7,252 (NYC)

    Number of Medicaid recipients filling at least one prescription for Truvada within the calendar year. Source: NYS Medicaid Data Warehouse

    *Data displayed for New York City comes from the NYC DOHMH HIV Surveillance System, unless otherwise noted, reported as of March 31, 2020. 2020 NYS statewide goals are displayed in all instances except for the NYC-specific ETE 2020 goals for new HIV infections (660) and new HIV diagnoses (1,350).